NCT04145518View on ClinicalTrials.gov

Mechanistic Characterization of Uterine Pain

PHASE4RecruitingINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

October 25, 2019

Primary Completion Date

August 29, 2025

Study Completion Date

August 29, 2025

Conditions
Dysmenorrhea (Disorder)Dysmenorrhea PrimaryDysmenorrhea SecondaryEndometrial DiseasesLeiomyomaFibroid Uterus
Interventions
DRUG

Naproxen Sodium

Participants will be randomized to take either a placebo pill or a single 550 mg naproxen sodium pill.

Trial Locations (1)

60201

RECRUITING

NorthShore University HealthSystem, Evanston

Sponsors

Lead Sponsor

Endeavor Health
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Endeavor Health

OTHER